Acolyte Biomedica Ltd. Release: Biotech Company Leads Fight Against Hospital Superbugs

A company at the forefront of the fight against the MRSA superbug is developing new technology to speed up tests for other potentially deadly hospital infections. Acolyte Biomedica, which is based at the Tetricus bioscience business incubator at Porton Down Science Park, near Salisbury, has developed a rapid MRSA screening test which reduces the time taken to diagnose the killer bug from days to just a few hours.
MORE ON THIS TOPIC